Table 2.
Number of patients using potential inappropriate medications before and after medication review. (n = 1720 patients)
| Before medication review | After medication review | p-valuea | |||||
|---|---|---|---|---|---|---|---|
| Total | Nursing home | Home care | Total | Nursing home | Home care | ||
| Patients with antipsychotics, n (%) | 194 (11.3) | 184 (12.2) | 10 (4.7) | 136 (7.9) | 128 (8.5) | 8 (3.8) | < 0.001 |
| Patients with anticholinergics, n (%) | 158 (9.2) | 139 (9.2) | 19 (9.0) | 72 (4.2) | 60 (4.0) | 12 (5.7) | < 0.001 |
| Patients with propiomazine, n (%) | 43 (2.5) | 33 (2.2) | 10 (4.7) | 16 (0.9) | 10 (0.7) | 6 (2.8) | < 0.001 |
| Patients with tramadol, n (%) | 90 (5.2) | 81 (5.2) | 9 (4.2) | 41 (2.4) | 39 (2.6) | 2 (0.9) | < 0.001 |
| Patients with long-acting benzodiazepines, n (%) | 112 (6.5) | 90 (6.0) | 22 (10.4) | 62 (3.6) | 51 (3.4) | 11 (5.2) | 0.001 |
| Patients with ≥1 PIMb, n (%) | 510 (29.7) | 453 (30.0) | 57 (26.9) | 299 (17.4) | 266 (17.6) | 33 (15.6) | < 0.001 |
| Patients with ≥3 psychotropics, n (%) | 395 (23.0) | 367 (24.3) | 28 (13.2) | 296 (17.2) | 274 (18.2) | 22 (10.4) | < 0.001 |
bPIM Potentially Inappropriate Medication (antipsychotics, anticholinergics, propiomazine, tramadol and long-acting benzodiazepines)
aChi square test between total numbers (nursing home and home care together)